Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virosomal vs Subunit Influenza Vaccine in Immunocompromised Patients
NCT00783380Phase 4Completed
- Sponsor
- Insel Gruppe
- Start
- Oct 2005
- Primary completion
- Jul 2006
- Modality
- Targeted Liposomes, Recombinant Protein Vaccines, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of virosomal influenza vaccine in influenza, sponsored by Insel Gruppe. Started Oct 2005; status: completed.
02
Drugs
virosomal influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00783380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783380.